Publication
International arbitration report
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
United States | Publication | July 2022
The US Occupational Safety and Health Administration (OSHA) announced on June 30, 2022, that it is extending its Revised National Emphasis Program for COVID-19 (NEP) until further notice. This occurs as OSHA continues to work on a permanent COVID healthcare standard.
Originally launched in March 2021, the NEP focuses enforcement efforts on companies that put the largest number of workers at "serious risk" of COVID infection. It also addresses employers who retaliate against workers who complain about unsafe or unhealthful conditions in the workplace.
OSHA also announced it is increasing its COVID-related inspection goal from five to 10 percent of total inspections. Citing the Centers for Disease Control and Prevention's reporting on increased national COVID hospitalization rates since April 2022, OSHA is prioritizing inspections at workplaces with higher exposure potential. These include hospitals, assisted living facilities, nursing homes, other healthcare and emergency response facilities and meat and poultry processing plants.
Since the onset of the pandemic in February 2020, OSHA has issued over 1,200 COVID-related citations and assessed penalties totaling US$7.2 million. OSHA has also pursued employers for claims of retaliation by over 400 workers who raised concerns about COVID, resulting in over US$5 million in monetary awards to the employees.
Publication
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023